U2MedTek Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
U2MedTek General Information
Description
Developer of a diagnostic device designed to treat rhinitis and insomnia. The company's devices are equipped with optical biomarkers and utilize optical image analysis technology and artificial intelligence technology to diagnose sinusitis and parathyroid gland location, enabling users to get relief from rhinitis and insomnia.
Contact Information
Website
www.u2medtek.comCorporate Office
- Unit 322, Building 251
- 50 UNIST-gil, Ulju-gun
- Ulsan
- South Korea
Corporate Office
- Unit 322, Building 251
- 50 UNIST-gil, Ulju-gun
- Ulsan
- South Korea
U2MedTek Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 01-Mar-2025 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 06-Jul-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 30-Jun-2019 | $511K | $511K | Completed | Generating Revenue | |
| 1. Seed Round | 20-Nov-2017 | Completed | Generating Revenue |
U2MedTek Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
U2MedTek Patents
U2MedTek Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023017920-A1 | Apparatus for extracting blood sugar level, using continuous blood glucose data, and method therefor | Inactive | 13-Aug-2021 | ||
| WO-2023017921-A1 | Glucose management device using continuous blood glucose data, and method therefor | Inactive | 13-Aug-2021 | ||
| WO-2021193996-A1 | Sinus diagnosis system and method for determining sinus state using same | Inactive | 26-Mar-2020 | ||
| WO-2021193997-A1 | System for diagnosing sinus and method for diagnosing sinus using same | Inactive | 26-Mar-2020 | A61B5/0075 |
U2MedTek Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
U2MedTek Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Gentium Partners | Accelerator/Incubator | Minority | ||
| G-Star Dreamers | Accelerator/Incubator | |||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority | ||
| Hyundai Venture Investment Corporation | Venture Capital | Minority |
U2MedTek FAQs
-
When was U2MedTek founded?
U2MedTek was founded in 2017.
-
Where is U2MedTek headquartered?
U2MedTek is headquartered in Ulsan, South Korea.
-
What is the size of U2MedTek?
U2MedTek has 5 total employees.
-
What industry is U2MedTek in?
U2MedTek’s primary industry is Diagnostic Equipment.
-
Is U2MedTek a private or public company?
U2MedTek is a Private company.
-
What is U2MedTek’s current revenue?
The current revenue for U2MedTek is .
-
How much funding has U2MedTek raised over time?
U2MedTek has raised $511K.
-
Who are U2MedTek’s investors?
MedTech Innovator, Gentium Partners, G-Star Dreamers, Tech Incubator Program for Startup, and Hyundai Venture Investment Corporation have invested in U2MedTek.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
